Early identification and standardized diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging inspections, laboratory tests and pathological activation. A platform can help align a team of authoritative experts at home and abroad to provide accurate diagnoses and treatment programs.
Treatment and management of the disease require individualized management, typically including drug therapy, rehabilitation interventions, regular follow-up, and other multidimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many of the neural system disorders that have been difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely scheduling according to changes in the condition.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of congenital coronary artery disease. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.